Market Overview

Cara Therapeutics (NASDAQ: CARA)

22.16 -0.78 (-3.40%)

Analyst Ratings

DateResearch FirmActionCurrentPT
7/30/19Piper JaffrayMaintainsOverweight39.0
5/29/19H.C. WainwrightMaintainsBuy28.0
5/29/19NeedhamMaintainsBuy35.0
2/06/19JefferiesAssumesBuy22.0
1/15/19Bank of AmericaInitiates Coverage OnNeutral19.0
9/21/18Cantor FitzgeraldInitiates Coverage OnOverweight27.0
9/13/18JefferiesInitiates Coverage OnBuy30.0
8/15/18Canaccord GenuityMaintainsBuy24.0
8/08/18Stifel NicolausMaintainsBuy26.0
6/29/18Canaccord GenuityMaintainsBuy22.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter